Acceder

Publicaciones - Farmacología Clínica y Experimental

Cargando...
Galecio, JS; Escudero, E; Egas, D; Mena, L; Badillo, E; Hernandis, V; Marin, P. Disposition kinetics of tildipirosin in alpacas after parenteral administrations. SMALL RUMINANT RESEARCH. 2023; 229. 10.1016/j.smallrumres.2023.107148
AÑO: 2023; IF: 1.8
Garcia-Carmona JA, Amores-Iniesta J, Soler-Usero J, Cerdan-Sanchez M, Navarro-Zaragoza J, Lopez-Lopez M, Soria-Torrecillas JJ, Ballesteros-Arenas A, Perez-Vicente JA, Almela P. Upregulation of Heat-Shock Protein (hsp)-27 in a Patient with Heterozygous SPG11 c.1951C>T and SYNJ1 c.2614G>T Mutations Causing Clinical Spastic Paraplegia. Genes (Basel). 2023 Jun 23;14(7):1320. doi: 10.3390/genes14071320. PubMed PMID: 37510225; PubMed Central PMCID: PMC10379220.
AÑO: 2023; IF: 4.141
37510225
Galecio, JS; Badillo, E; Escudero, E; Corrales, JC; Yuste, MT; Marín, P. Antimicrobial Susceptibility of Pasteurella multocida Isolated from Sheep with Fibrinous Pneumonia. ACTA VETERINARIA-BEOGRAD. 2023; 73(2):171-178. 10.2478/acve-2023-0013
AÑO: 2023; IF: 0.6
Herrero MT, Yuste JE, Cuenca-Bermejo L, Almela P, Arenas-Betancur L, De Pablos V, Gonzalez-Cuello A, Del Bel E, Navarro-Zaragoza J, Fernandez-Villalba E. 7-Nitroindazole reduces L-DOPA-induced dyskinesias in non-human Parkinsonian primate. Open Biol. 2023 May;13(5):220370. doi: 10.1098/rsob.220370. Epub 2023 May 17. PubMed PMID: 37192671; PubMed Central PMCID: PMC10188238.
AÑO: 2023; IF: 7.124
37192671
Garcia-Carmona JA, Garcia-Perez A, Isidro Garcia G, Forcen-Munoz LA, Ovejero Garcia S, Saez Povedano R, Gonzalez-Galdamez AL, Mata Iturralde L, Hernandez-Sanchez F, Ramirez Bonilla M, Fuentes-Perez P, Ovejas-Catalan C, Suarez-Pinilla P, Valdivia-Munoz F, Fernandez Abascal B, Omana Colmenares M, de Lourdes Martin-Perez A, Campos-Navarro MP, Baca-Garcia E, Benavente-Lopez S, Raya Platero A, Barberan Navalon M, Sanchez-Alonso S, Vazquez-Bourgon J, Pappa S. Preliminary data from a 4-year mirror-image and multicentre study of patients initiating paliperidone palmitate 6-monthly long-acting injectable antipsychotic: the Paliperidone 2 per Year study. Ther Adv Psychopharmacol. 2023 Dec 26;13:20451253231220907. doi: 10.1177/20451253231220907. eCollection 2023. PubMed PMID: 38152569; PubMed Central PMCID: PMC10752040.
AÑO: 2023; IF: 4.2
38152569
< AnteriorSiguiente >
IMIB-Arrixaca

Instituto de Investigación Sanitaria Acreditado

ISCII

Farmacología Clínica y Experimental